Skip to main content
    P

    PMGC Holdings Inc. (ELAB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.66
    +0.08 (+5.06%)

    Market Cap: $1.28M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    PMGC Holdings Inc. (ELAB) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to PMGC Holdings are Enlivex Therapeutics (ENLV), GeoVax Labs (GOVX) and Silexion Therapeutics (SLXN). By market cap, PMGC Holdings ranks 10th of the 13 companies on this page; Bioatla (BCAB) is the largest at $2.89M.

    Peer Comparison

    ELAB's revenue growth of -45.8% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    PMGC Holdings (ELAB)$1.28MN/A0.3x0.0%-40.3%-45.8%0.00%
    Enlivex Therapeutics Ltd (ENLV)$1.82MN/AN/A0.0%-0.3%0.0%0.00%
    GeoVax Labs Inc (GOVX)$928290N/AN/A0.0%N/A-100.0%0.00%
    Silexion Therapeutics Corp (SLXN)$1.29MN/A5.9x0.0%N/A0.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    Scinai Immunotherapeutics Ltd (SCNI)$1.05MN/AN/A-80.1%N/A572.0%0.00%
    Virax Biolabs Group Limited Ordinary Shares (VRAX)$823940N/A14.3x0.0%N/A685.0%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    VivoSim Labs, Inc. (VIVS)$2.58MN/A15.1x0.0%N/A-51.4%0.00%
    Bioatla Inc (BCAB)$2.89MN/AN/A0.0%N/A31.6%0.00%
    Calidi Biotherapeutics Inc. (CLDI)$2.29MN/AN/A0.0%N/A0.0%0.00%
    Genprex Inc (GNPX)$1.71MN/AN/A0.0%N/A0.0%0.00%
    Onconetix Inc (ONCO)$2.15MN/A1.0x0.0%N/A-83.9%0.00%
    Peer median$1.76MN/A10.1x0.0%-0.3%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to PMGC Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Enlivex Therapeutics Ltd (ENLV)
    Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel.
    ENLV competitors
    GeoVax Labs Inc (GOVX)
    GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified...
    GOVX competitors
    Silexion Therapeutics Corp (SLXN)
    Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine...
    SLXN competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    Scinai Immunotherapeutics Ltd (SCNI)
    Scinai Immunotherapeutics Ltd is an innovative biotechnology company focused on developing cutting-edge immunotherapy solutions for cancer and autoimmune...
    SCNI competitors
    Virax Biolabs Group Limited Ordinary Shares (VRAX)
    Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE...
    Revelation Biosciences Inc (REVB)
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    VivoSim Labs, Inc. (VIVS)
    VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.
    VIVS competitors
    Bioatla Inc (BCAB)
    BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers.
    BCAB competitors
    Calidi Biotherapeutics Inc. (CLDI)
    Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer.
    CLDI competitors
    Genprex Inc (GNPX)
    Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes.
    GNPX competitors
    Onconetix Inc (ONCO)
    Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions.
    ONCO competitors

    Frequently Asked Questions About ELAB

    Who are PMGC Holdings' main competitors?

    The companies most similar to PMGC Holdings include Enlivex Therapeutics (ENLV), GeoVax Labs (GOVX), Silexion Therapeutics (SLXN), Kairos Pharma (KAPA) and Scinai Immunotherapeutics (SCNI), listed from the closest match.

    Who is PMGC Holdings' biggest competitor?

    Bioatla (BCAB) is the largest of the similar companies at $2.89M; Enlivex Therapeutics (ENLV) is the closest match by business profile, size, sector and industry.

    How does ELAB stock compare with its competitors?

    ELAB's P/S is 0.3x against a peer median of 10.1x; its net margin is 0.0% against a peer median of 0.0%.

    Which of PMGC Holdings' competitors pays a higher dividend?

    PMGC Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is PMGC Holdings bigger than its competitors?

    No. PMGC Holdings is 10th by market cap among the 13 companies on this page; the largest is Bioatla (BCAB) at $2.89M.